ICOSLG (inducible T cell costimulator ligand)

2007-02-01  

Identity

HGNC
LOCATION
21q22.3
LOCUSID
ALIAS
B7-H2,B7H2,B7RP-1,B7RP1,B7h,CD275,GL50,ICOS-L,ICOSL,LICOS
FUSION GENES

Other Information

Locus ID:

NCBI: 23308
MIM: 605717
HGNC: 17087
Ensembl: ENSG00000160223

Variants:

dbSNP: 23308
ClinVar: 23308
TCGA: ENSG00000160223
COSMIC: ICOSLG

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000160223ENST00000344330O75144
ENSG00000160223ENST00000400377O75144
ENSG00000160223ENST00000400379K4DIA0
ENSG00000160223ENST00000407780O75144
ENSG00000160223ENST00000407780A0N0L8
ENSG00000160223ENST00000643466A0A2R8Y5W7

Expression (GTEx)

0
1
2

Pathways

PathwaySourceExternal ID
Cell adhesion molecules (CAMs)KEGGko04514
Cell adhesion molecules (CAMs)KEGGhsa04514
Intestinal immune network for IgA productionKEGGko04672
Intestinal immune network for IgA productionKEGGhsa04672
Immune SystemREACTOMER-HSA-168256
Adaptive Immune SystemREACTOMER-HSA-1280218
Costimulation by the CD28 familyREACTOMER-HSA-388841

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
378478582024Epstein-Barr virus-encoded EBNA2 downregulates ICOSL by inducing miR-24 in B-cell lymphoma.2
380813392024ICOSLG acts as an oncogene to promote glycolysis, proliferation, migration, and invasion in gastric cancer cells.1
378478582024Epstein-Barr virus-encoded EBNA2 downregulates ICOSL by inducing miR-24 in B-cell lymphoma.2
380813392024ICOSLG acts as an oncogene to promote glycolysis, proliferation, migration, and invasion in gastric cancer cells.1
378505012023Expression and prognosis of inducible T-cell co-stimulator and its ligand in Chinese stage I-III lung adenocarcinoma patients.1
380773342023Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis.1
378505012023Expression and prognosis of inducible T-cell co-stimulator and its ligand in Chinese stage I-III lung adenocarcinoma patients.1
380773342023Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis.1
336621682021Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS-ICOSL interaction.10
341854222021Activated neutrophils polarize protumorigenic interleukin-17A-producing T helper subsets through TNF-α-B7-H2-dependent pathway in human gastric cancer.9
336621682021Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS-ICOSL interaction.10
341854222021Activated neutrophils polarize protumorigenic interleukin-17A-producing T helper subsets through TNF-α-B7-H2-dependent pathway in human gastric cancer.9
319988012020The ICOSL Expression Predicts Better Prognosis for Nasopharyngeal Carcinoma via Enhancing Oncoimmunity.1
330332552020Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies.17
330512402020Dysregulated NF-κB-Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma.12

Citation

Dessen P

ICOSLG (inducible T cell costimulator ligand)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/46042/icoslg